Inventor
Suzanne HARTFORD
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes26%
A01KAnimal husbandry21%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides11%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations5%
C12YEnzymes5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
PatentTitleYear
12,529,072Transcription modulation in animals using CRISPR/CAS systems202612,010,979Non-human animals comprising a humanized TTR locus and methods of use202411,866,794Cas-ready mouse embryonic stem cells and mice and uses thereof202411,519,004Transcription modulation in animals using CRISPR/Cas systems202211,485,958HSD17B13 variants and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to REGENERON PHARMA (5)· patent assignee history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 5 | 2022–2026 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2026 |